Keyora Skin Systems Nutrition - Elastin Peptide EP-6: The Periorbital Wrinkle and Fine-Line Clinical Evidence Matrix: Human Oral Elastin Peptide Interventions, Three-Dimensional Skin Topography, and Hydration Outcomes

Background Visible skin aging encompasses periorbital wrinkles, superficial fine lines, irregular surface topography, and hydration-related changes. Although these phenotypes contribute collectively to skin appearance, they represent distinct morphological, physiological, and biophysical outcomes requiring independent clinical measurements. Objective and Scientific Framework This five-chapter narrative synthesis develops the Keyora Wrinkle and Visible Skin Aging Response Matrix, integrating clinical phenotype classification, human oral elastin peptide evidence, quantitative surface profilometry, stratum corneum hydration, and preparation-specific nutritional interpretation. The framework connects recognizable skin concerns with appropriate measurement methods and clinically interpretable outcomes. Mechanistic Foundations Periorbital wrinkle morphology reflects regional anatomy, orbicularis oculi activity, repeated skin deformation, and dermal extracellular matrix organization. Elastin-rich fibers contribute mechanical recovery, whereas stratum corneum hydration depends on corneocyte organization, natural moisturizing factors, and intercellular lipids. Shiratsuchi et al. (2016) reported enhanced human dermal fibroblast proliferation and elastin synthesis following experimental exposure to fish-derived elastin hydrolysate, with maximal proliferation observed at 25 ng/mL Pro-Gly. The associated human ingestion research reported approximately 4% elasticity improvement compared with 2% in placebo, alongside wrinkle-related and blood-flow observations. Chapter 1: Visible Skin Aging and Clinical Phenotypes. Fine lines, established wrinkles, dynamic expression lines, and static wrinkles are classified according to morphology, anatomical distribution, and facial expression. The Keyora Clinical Phenotype Matrix distinguishes wrinkle geometry, surface microrelief, and stratum corneum hydration, connecting recognizable skin concerns with appropriate clinical assessment endpoints. Chapter 2: Human Clinical Evidence of Oral Elastin Peptides. Seong et al. (2024) conducted a randomized, double-blind, placebo-controlled study involving 100 Korean adults aged 35-60 years, investigating 100 mg/day of bonito-derived VGPG Elastin, with an average molecular weight of 582 Da, for 12 weeks. The efficacy population comprised 84 participants. At week 12, between-group differences favored elastin peptide intervention across five PRIMOS parameters: Ra (p<0.0001), Rmax (p<0.0001), Rp (p=0.0420), Rv (p=0.0003), and Rz (p<0.0001). Crow's-feet severity changed from 3.92 to 3.87 in the intervention group versus 4.19 to 4.33 in placebo, with a significant between-group difference in change (p=0.0365). Complementary research includes Shiratsuchi et al. (2016), examining fish elastin hydrolysate and Pro-Gly-associated fibroblast responses, and Shiratsuchi (2021), investigating 75 mg/day of skipjack-tuna-derived elastin peptides for eight weeks. Chapter 3: Objective Skin Surface Topography. The Keyora Objective Wrinkle Geometry Interpretation Framework integrates non-contact three-dimensional optical reconstruction, anatomical registration, standardized photography, and complementary roughness parameters. Average roughness, maximum peak-to-valley height, peak height, valley depth, and composite profile height provide distinct quantitative descriptions of surface morphology. Chapter 4: Skin Hydration and Visible Improvement. In Seong et al. (2024), Corneometer hydration increased from 42.05 to 46.29 arbitrary units in the intervention group and from 42.78 to 45.84 in placebo, with a significant between-group difference in change (p=0.0160). Eye-region elevation volume increased from 11.12 to 15.22 mm³, interpreted by the investigators as skin plumping. Additional human moisture findings are discussed through Shiratsuchi (2021) and Inoue and Shiratsuchi (2026). Hydration, transepidermal water loss, and dermal elasticity remain distinct physiological endpoints. Chapter 5: Integrated Keyora Framework. The Keyora Periorbital Wrinkle Assessment Map, Skin Surface Topography Map, Hydration-to-Visible Fine-Line Interpretation Axis, and Endpoint-to-Concern Matching Framework integrate three complementary clinical domains. Preparation-specific interpretation distinguishes the tested bonito-derived intervention from Keyora's tilapia-derived elastin peptide ingredient at 20 mg per two-tablet serving. Human Clinical Evidence Seong et al. (2024) randomized 100 Korean adults aged 35-60 years to 100 mg/day of bonito-derived VGPG Elastin or placebo for twelve weeks. The per-protocol efficacy population comprised 84 participants. At week twelve, all five PRIMOS profilometry parameters demonstrated favorable between-group differences: Ra, Rmax, and Rz (p < 0.0001), Rp (p = 0.0420), and Rv (p = 0.0003). Intervention-group Ra decreased from 19.54 to 18.07 μm, while Rmax decreased from 180.10 to 172.65 μm. Three-dimensional eye-region volume increased from 11.12 to 15.22 mm³, interpreted by the investigators as skin plumping. Visual crow's-feet scores changed from 3.92 to 3.87 without significant within-group improvement, although the between-group difference in change was significant (p = 0.0365). Corneometer hydration increased from 42.05 to 46.29 arbitrary units versus 42.78 to 45.84 with placebo (between-group p = 0.0160). No test-product-related adverse events were reported. Additional Japanese investigations involving skipjack-tuna-derived elastin peptides contribute complementary hydration and skin-condition evidence. Integrated Scientific Interpretation The Keyora framework integrates standardized photographic grading, PRIMOS surface reconstruction, Ra/Rmax/Rp/Rv/Rz descriptors, regional volumetric assessment, and Corneometer measurements. Environmental standardization, anatomical consistency, instrument reproducibility, and longitudinal comparisons establish essential measurement controls. Hydration, transepidermal water loss, mechanical elasticity, and wrinkle geometry remain distinct endpoints. Evidence Boundaries and Conclusions Keyora declares 20 mg of tilapia-derived elastin peptides per two-tablet serving. Preparation identity, molecular composition, dose, population, duration, and endpoint must therefore be matched before interpreting external clinical findings. The available human evidence supports the skin-related intervention potential of specific fish-derived elastin peptide preparations, particularly for periorbital wrinkle morphology, surface roughness, and superficial hydration. The Keyora Wrinkle and Visible Skin Aging Response Matrix provides an integrated, clinically interpretable research framework without assuming direct efficacy equivalence between the investigated preparations and the finished Keyora formulation.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24415049
Primary Topic
Skin Protection and Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Keyora Skin Systems Nutrition - Elastin Peptide EP-6: The Periorbital Wrinkle and Fine-Line Clinical Evidence Matrix: Human Oral Elastin Peptide Interventions, Three-Dimensional Skin Topography, and Hydration Outcomes

Xu Jin
Zenodo (CERN European Organization for Nuclear Research)
Skin Protection and Aging
article

Keyora Skin Systems Nutrition - Elastin Peptide EP-6: The Periorbital Wrinkle and Fine-Line Clinical Evidence Matrix: Human Oral Elastin Peptide Interventions, Three-Dimensional Skin Topography, and Hydration Outcomes

Xu Jin
article en

Abstract

Background Visible skin aging encompasses periorbital wrinkles, superficial fine lines, irregular surface topography, and hydration-related changes. Although these phenotypes contribute collectively to skin appearance, they represent distinct morphological, physiological, and biophysical outcomes requiring independent clinical measurements. Objective and Scientific Framework This five-chapter narrative synthesis develops the Keyora Wrinkle and Visible Skin Aging Response Matrix, integrating clinical phenotype classification, human oral elastin peptide evidence, quantitative surface profilometry, stratum corneum hydration, and preparation-specific nutritional interpretation. The framework connects recognizable skin concerns with appropriate measurement methods and clinically interpretable outcomes. Mechanistic Foundations Periorbital wrinkle morphology reflects regional anatomy, orbicularis oculi activity, repeated skin deformation, and dermal extracellular matrix organization. Elastin-rich fibers contribute mechanical recovery, whereas stratum corneum hydration depends on corneocyte organization, natural moisturizing factors, and intercellular lipids. Shiratsuchi et al. (2016) reported enhanced human dermal fibroblast proliferation and elastin synthesis following experimental exposure to fish-derived elastin hydrolysate, with maximal proliferation observed at 25 ng/mL Pro-Gly. The associated human ingestion research reported approximately 4% elasticity improvement compared with 2% in placebo, alongside wrinkle-related and blood-flow observations. Chapter 1: Visible Skin Aging and Clinical Phenotypes. Fine lines, established wrinkles, dynamic expression lines, and static wrinkles are classified according to morphology, anatomical distribution, and facial expression. The Keyora Clinical Phenotype Matrix distinguishes wrinkle geometry, surface microrelief, and stratum corneum hydration, connecting recognizable skin concerns with appropriate clinical assessment endpoints. Chapter 2: Human Clinical Evidence of Oral Elastin Peptides. Seong et al. (2024) conducted a randomized, double-blind, placebo-controlled study involving 100 Korean adults aged 35-60 years, investigating 100 mg/day of bonito-derived VGPG Elastin, with an average molecular weight of 582 Da, for 12 weeks. The efficacy population comprised 84 participants. At week 12, between-group differences favored elastin peptide intervention across five PRIMOS parameters: Ra (p<0.0001), Rmax (p<0.0001), Rp (p=0.0420), Rv (p=0.0003), and Rz (p<0.0001). Crow's-feet severity changed from 3.92 to 3.87 in the intervention group versus 4.19 to 4.33 in placebo, with a significant between-group difference in change (p=0.0365). Complementary research includes Shiratsuchi et al. (2016), examining fish elastin hydrolysate and Pro-Gly-associated fibroblast responses, and Shiratsuchi (2021), investigating 75 mg/day of skipjack-tuna-derived elastin peptides for eight weeks. Chapter 3: Objective Skin Surface Topography. The Keyora Objective Wrinkle Geometry Interpretation Framework integrates non-contact three-dimensional optical reconstruction, anatomical registration, standardized photography, and complementary roughness parameters. Average roughness, maximum peak-to-valley height, peak height, valley depth, and composite profile height provide distinct quantitative descriptions of surface morphology. Chapter 4: Skin Hydration and Visible Improvement. In Seong et al. (2024), Corneometer hydration increased from 42.05 to 46.29 arbitrary units in the intervention group and from 42.78 to 45.84 in placebo, with a significant between-group difference in change (p=0.0160). Eye-region elevation volume increased from 11.12 to 15.22 mm³, interpreted by the investigators as skin plumping. Additional human moisture findings are discussed through Shiratsuchi (2021) and Inoue and Shiratsuchi (2026). Hydration, transepidermal water loss, and dermal elasticity remain distinct physiological endpoints. Chapter 5: Integrated Keyora Framework. The Keyora Periorbital Wrinkle Assessment Map, Skin Surface Topography Map, Hydration-to-Visible Fine-Line Interpretation Axis, and Endpoint-to-Concern Matching Framework integrate three complementary clinical domains. Preparation-specific interpretation distinguishes the tested bonito-derived intervention from Keyora's tilapia-derived elastin peptide ingredient at 20 mg per two-tablet serving. Human Clinical Evidence Seong et al. (2024) randomized 100 Korean adults aged 35-60 years to 100 mg/day of bonito-derived VGPG Elastin or placebo for twelve weeks. The per-protocol efficacy population comprised 84 participants. At week twelve, all five PRIMOS profilometry parameters demonstrated favorable between-group differences: Ra, Rmax, and Rz (p < 0.0001), Rp (p = 0.0420), and Rv (p = 0.0003). Intervention-group Ra decreased from 19.54 to 18.07 μm, while Rmax decreased from 180.10 to 172.65 μm. Three-dimensional eye-region volume increased from 11.12 to 15.22 mm³, interpreted by the investigators as skin plumping. Visual crow's-feet scores changed from 3.92 to 3.87 without significant within-group improvement, although the between-group difference in change was significant (p = 0.0365). Corneometer hydration increased from 42.05 to 46.29 arbitrary units versus 42.78 to 45.84 with placebo (between-group p = 0.0160). No test-product-related adverse events were reported. Additional Japanese investigations involving skipjack-tuna-derived elastin peptides contribute complementary hydration and skin-condition evidence. Integrated Scientific Interpretation The Keyora framework integrates standardized photographic grading, PRIMOS surface reconstruction, Ra/Rmax/Rp/Rv/Rz descriptors, regional volumetric assessment, and Corneometer measurements. Environmental standardization, anatomical consistency, instrument reproducibility, and longitudinal comparisons establish essential measurement controls. Hydration, transepidermal water loss, mechanical elasticity, and wrinkle geometry remain distinct endpoints. Evidence Boundaries and Conclusions Keyora declares 20 mg of tilapia-derived elastin peptides per two-tablet serving. Preparation identity, molecular composition, dose, population, duration, and endpoint must therefore be matched before interpreting external clinical findings. The available human evidence supports the skin-related intervention potential of specific fish-derived elastin peptide preparations, particularly for periorbital wrinkle morphology, surface roughness, and superficial hydration. The Keyora Wrinkle and Visible Skin Aging Response Matrix provides an integrated, clinically interpretable research framework without assuming direct efficacy equivalence between the investigated preparations and the finished Keyora formulation.

Zenodo (CERN European Organization for Nuclear Research)
Skin Protection and Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon